Page 52 - Coronavirus Vaccine

Over 80% of India's youngsters get vax first dose, total coverage 1.9 bn

In another tweet, Mandaviya said that over 70 per cent of teenagers between 12-14 age bracket have also received the first dose of vaccine

China's bet on homegrown coronavirus vaccines holds back country

China is trying to navigate its biggest coronavirus outbreak without a tool it could have adopted many months ago, the kind of vaccines that have proven to offer the best protection against Covid

Pfizer's three-dose coronavirus vaccine 80% effective in young kids

Pfizer said that preliminary clinical data showed their three-dose Covid-19 vaccine regimen was 80 per cent effective for children aged between 6 months to 5-years-old

India expresses disappointment over WHO's Covid mortality report

India expressed dismay and concern over the WHO's recent report on all-cause excess mortality estimates, saying authentic data published by the statutory authority has not been taken into account.

Cyrus Poonawalla gets top Johns Hopkins honour for developing Covid vaccine

The SII, with its Covid-19 vaccines, played a huge role in fighting the Coronavirus pandemic that raged across the world in the past over two years.

BA.4 variant patient fully recovered, no spread in Tamil Nadu: Health Secy

Tamil Nadu's first case of covid-19 Omicron BA. 4 sub lineage variant is a teenager and a part of a four-member family with no travel history and had taken two jabs of the vaccine against the virus.

Pfizer/BioNTech say three Covid shots generate good response in under-5s

Three doses of Pfizer's COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday.

Data story: India logs 2,022 new Covid cases; death toll at 524,459

India has so far administered 1,923,845,615 vaccine doses

Africa's coronavirus cases pass 11.59 mn, death toll stands at 252,892

South Africa, Morocco, Tunisia and Libya are among the countries with the most cases on the continent, said the Africa CDC

SII seeks permission for trial of Covovax as booster for ages 2 to18 yrs

SII has sought permission from country's drug regulator to conduct Phase-3 trial to evaluate safety and immunogenicity of its COVID vaccine Covovax as a booster dose in children aged two to 18 years

Covid: Delhi sees 365 fresh cases, one more death, positivity rate at 1.97%

Delhi on Sunday reported 365 fresh COVID-19 cases and one more death, while the positivity rate stood at 1.97 per cent, according to data shared by the city health department. With this, Delhi's COVID-19 caseload increased to 19,03,554 and the death toll climbed to 26,201. A total of 18,543 COVID-19 tests were conducted in the national capital the previous day, the department said in its latest bulletin. Delhi had logged 479 COVID-19 cases on Saturday with a positivity rate of 2.06 per cent and one death. The city saw 530 cases and zero deaths on Friday, while the positivity rate stood at 2.17 per cent. On Thursday, the capital recorded 520 cases with a positivity rate of 2.09 per cent and one death. The number of daily COVID-19 cases in Delhi had touched the record high of 28,867 on January 13 this year during the third wave of the pandemic. The city had recorded a positivity rate of 30.6 percent on January 14, the highest during the third wave of the pandemic. The number of a

Covid-19: INSACOG confirms presence of BA.4, BA.5 Omicron variants in India

The Indian SARS-CoV-2 Genomics Consortium (INSACOG) on Sunday confirmed the first case of BA.4 and BA.5 variants of Covid-19 in India.

3 US Air Force cadets who refused Covid vaccine not commissioned

Across the military, the Army, Navy, Air Force and Marine Corps have discharged as many as 4,000 active duty service members for refusing the vaccine

530 fresh Coronavirus cases in Delhi; positivity rate at 2.17%

Delhi reported 530 new COVID-19 cases and zero fatality due to the disease on Friday, while the positivity rate stood at 2.17 per cent, according to data shared by the city health department. With the new infections, Delhi's COVID-19 caseload increases to 19,02,710, while the death toll stands at 26,199. A total of 24,458 Covid tests were conducted in the city a day ago, the department said in its latest bulletin. The capital had on Thursday logged 520 Covid cases with a positivity rate of 2.09 per cent and one death due to the disease. It saw 532 COVID-19 cases and zero fatality due to the disease on Wednesday, while the positivity rate was recorded at 2.13 percent. On Tuesday, the national capital had recorded 393 COVID-19 cases with a positivity rate of 3.35 per cent and two deaths. The number of daily COVID-19 cases in Delhi had touched the record high of 28,867 on January 13 during the third wave of the pandemic. The city had recorded a positivity rate of 30.6 percent on Ja

Covid booster needed for protection against Omicron variants, studies show

A COVID-19 booster dose will provide strong and broad antibody protection against Omicron sublineage variants of the SARS-CoV-2 virus, two new studies using serum from human blood samples suggest. Researchers from the Ohio State University in the US tested neutralising antibody levels against the BA.2 and BA.3 Omicron variants and Deltacron, a recombinant variant created by the exchange of genetic material between Delta and Omicron. The studies, published in the New England Journal of Medicine (NEJM), and Cell Host & Microbe journal, showed that a third mRNA vaccine dose was required to generate a high enough concentration of antibodies to neutralise BA.2 and Deltacron, as well as other Omicron variants, including the original BA.1, and BA.1.1. Antibodies produced by just the two-dose series of mRNA vaccines were enough to neutralise BA.3 -- a sign this variant is not likely to produce a new surge of Omicron infections, the researchers said. "Three doses is better for everything,"

India supplies non-J&J vaccines to Cambodia, Thailand under Quad umbrella

NEW DELHI (Reuters) -India has supplied COVID-19 vaccines to Cambodia and Thailand under an initiative of the Quad group of countries, New Delhi said on Thursday, though not the Johnson & Johnson shot as originally planned.

Top Headlines: IMF's prediction, GST Council recommendations, and more

The International Monetary Fund (IMF) has "corrected" an error in its calculations to now project that India would become a $5-trillion economy by 2026-27

India-developed 'variant-proof' Covid vaccine likely in 2-3 years: Industry

Domestically produced variant-proof jabs are part of a global project to develop vaccines for future epidemics

WHO clears China's CanSino Covid-19 vaccination for emergency use

The WHO on Thursday said it has granted an emergency use authorisation for the coronavirus vaccine made by China's CanSino Biologics, the 11th such shot to receive the green light.

Covid: 520 new cases, one more death in Delhi; positivity rate 2.09%

Delhi recorded 520 new Covid cases and one more death on Thursday while the positivity rate declined to 2.09 percent, according to data shared by the city health department here. With the new cases, Delhi's COVID-19 caseload increased to 19,02,180, while the death toll rose to 26,199. A total of 24,918 Covid tests were conducted here a day ago, the department said in its latest bulletin. The national capital logged 532 fresh COVID-19 cases and zero fatality due to the disease on Wednesday, while the positivity rate was recorded at 2.13 percent.